Assessing Market Dominance Competition within the biologics space is no longer limited to a few massive conglomerates. The Rituximab Market Share is increasingly fragmented as specialized biotech firms launch successful biosimilar versions of the drug. Major players are responding by forming strategic alliances or acquiring smaller firms to protect their market position. This...